Le cycle de séminaires des Frontiers in Biomedicine (anciennement "Frontiers in Biology"), initié par la Faculté de médecine en 2003 par les départements de la Section de médecine fondamentale, a pour but d’établir un pont entre médecine et biologie à travers une série de 8 à 10 conférences annuelles.
Des intervenants de renommée mondiale, actifs dans le domaine des sciences de la médecine, sont invités à présenter leur travail à un large public scientifique et médical. Les conférences sont données en anglais.

The Frontiers In Biomedicine (initially "Frontiers in Biology") lecture series was initiated in 2003 at Geneva University’s Faculty of Medicine. The series aims to bridge the gap between biology and medicine through a cycle of eight to ten seminars per year. World-class guest speakers from all domains of the basic medical sciences are invited to present broadly accessible lectures to a non-specialist scientific audience.

2011 - 2012

Thursdays, 12.30 - 13.30
CMU - A250

Next Seminar:

All seminars:

Date	Speaker	Institution	Host	Title	Dept.
29.9.11	Dr Phil HOLLIGER	MRC Laboratory of Molecular Biology, Cambridge, UK	Olivier Hartley	Reconstructing the RNA World	BIINF
15.12.11	Pr Emmanuel VAN OBBERGHEN	Reporté	Reporté	Reporté	Reporté
12.01.12	Pr Hendrik STUNNENBERG	The Radboud University Nijmegen Medical Centre, Netherlands	Emmanouil Dermitzakis	The Epigenomic Blueprint of Stem Cells	GEDEV
23.02.12	Pr Victor THANNICKAL	Ben Vaughan Branscomb Chair in Respiratory Disease, University of Alabama at Birmingham, USA	Karl-Heinz Krause	Novel Roles for Reactive Oxygen in Innate Immunity and Fibrosis	PATIM
15.03.12 JOINT SYMPOSIUM Prof Pelicci & Prof Hengartner		"CANCER: FROM DEATH TO RESURRECTION APOPTOSIS & STEM CELLS BIOLOGY"
15.03.12 12H15-13H00	Pr Pier Giuseppe PELICCI	Scientific Co-Director, Chairman of Experimental Oncology Dept., IEO (European Institute of Oncology), Milan	Luca Scorrano	Regulation of Self-renewal in Cancer Stem Cells	PHYME
15.03.12 13H15-14H00	Pr Michael HENGARTNER	Dean, Faculty of Science, Institute of Molecular Life Science, University of Zürich	Dominique Belin	C.Elegans	PATIM
26.04.12	Pr Douglas HANAHAN	Director, Swiss Institute for Experimental Cancer Research,  ISREC; Molecular Oncology, School Of Life Sciences, (EPFL)	Beat Imhof	Translational Therapeutic Oncology: Linking Pre-Clinical and Clinical Cancer Trials	PATIM
10.05.12	Pr Adolfo GARCIA-SASTRE	Dpmts of Microbiology and Medicine, Division of Infectious Diseases Director, Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York	Laurent Roux	Induction and Evasion of Type I Interferon Responses by RNA Viruses	MIMOL
24.05.12	Pr Emmanuel VAN OBBERGHEN	Université de Nice, France	Jean-Louis Carpentier	Novel insights on dysregulations of insulin action and secretion and their contribution to diabetes	PHYME